United Therapeutics Corp
(STU:UTH)
€
283.3
8.1 (2.94%)
Market Cap: 12.64 Bil
Enterprise Value: 10.68 Bil
PE Ratio: 14.47
PB Ratio: 2.53
GF Score: 87/100 - Q1 2024 United Therapeutics Corp Earnings Call TranscriptMay 01, 2024Earnings
- United Therapeutics Corp at TD Cowen Health Care Conference TranscriptMar 05, 2024
- Q4 2023 United Therapeutics Corp Earnings Call TranscriptFeb 21, 2024€198.15 (-0.03%)Earnings
- United Therapeutics Corp at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- United Therapeutics Corp at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 United Therapeutics Corp Earnings Call TranscriptNov 01, 2023€211.1 (+2.13%)Earnings
- United Therapeutics Corp at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 United Therapeutics Corp Earnings Call TranscriptAug 02, 2023€215.3 (-1.78%)Earnings
- Q1 2023 United Therapeutics Corp Earnings Call TranscriptMay 03, 2023€206.2 (-0.34%)Earnings
- United Therapeutics Corp at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- United Therapeutics Corp at Cowen Health Care Conference TranscriptMar 07, 2023
- Q4 2022 United Therapeutics Corp Earnings Call TranscriptFeb 22, 2023€239.1 (-0.04%)Earnings
- United Therapeutics Corp at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- United Therapeutics Corp at Credit Suisse Healthcare Conference TranscriptNov 08, 2022
- Q3 2022 United Therapeutics Corp Earnings Call TranscriptNov 02, 2022€241.5 (+4.46%)Earnings
- Q2 2022 United Therapeutics Corp Earnings Call TranscriptAug 03, 2022€220.8 (+0.64%)Earnings
- United Therapeutics Corp at Jefferies Healthcare Conference TranscriptJun 09, 2022
- Q1 2022 United Therapeutics Corp Earnings Call TranscriptMay 04, 2022€173.75 (+1.76%)Earnings
- United Therapeutics Corp at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 15, 2022
- United Therapeutics Corp at Cowen Health Care Conference (Virtual) TranscriptMar 08, 2022
- Q4 2021 United Therapeutics Corp Earnings Call TranscriptFeb 24, 2022€150 (-10.71%)Earnings
- United Therapeutics Corp Fireside Chat Hosted By JPMorgan TranscriptJan 06, 2022
- United Therapeutics Corp at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 08, 2021
- Q3 2021 United Therapeutics Corp Earnings Call TranscriptNov 03, 2021€177 (+6.63%)Earnings
- United Therapeutics Corp at Wedbush PacGrow Healthcare Conference (Virtual) TranscriptAug 11, 2021
- Q2 2021 United Therapeutics Corp Earnings Call TranscriptAug 04, 2021€152Earnings
- United Therapeutics Corp at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- Q1 2021 United Therapeutics Corp Earnings Call TranscriptMay 05, 2021€165 (+1.85%)Earnings
- United Therapeutics Corp at JPMorgan NAPA Valley Forum (Virtual) TranscriptMar 31, 2021
- United Therapeutics Corp at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 16, 2021
- United Therapeutics Corp at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Q4 2020 United Therapeutics Corp Earnings Call TranscriptFeb 24, 2021€144 (+2.86%)Earnings
- United Therapeutics Corp Announces the INCREASE Study Evaluating Tyvaso® in Pulmonary Hypertension Associated with Interstitial Lung Disease TranscriptJan 19, 2021
- United Therapeutics Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- United Therapeutics Corp at Jefferies Virtual London Healthcare Conference TranscriptNov 17, 2020
- United Therapeutics Corp at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2020
- Q3 2020 United Therapeutics Corp Earnings Call TranscriptOct 28, 2020€103Earnings
- United Therapeutics Corp at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) TranscriptSep 23, 2020
- United Therapeutics Corp at Wedbush PacGrow Healthcare Virtual Conference TranscriptAug 11, 2020
- Q2 2020 United Therapeutics Corp Earnings Call TranscriptJul 29, 2020€96 (-1.03%)Earnings
- United Therapeutics Corp at HMG New York Global Innovation Virtual Summit TranscriptJun 26, 2020
- United Therapeutics Corp Annual Shareholders Meeting TranscriptJun 26, 2020
- United Therapeutics Corp at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2020
- United Therapeutics Corp at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 13, 2020
- Q1 2020 United Therapeutics Corp Earnings Call TranscriptApr 29, 2020€102Earnings
- United Therapeutics Corp at Cowen HealthCare Conference TranscriptMar 03, 2020
- Q4 2019 United Therapeutics Corp Earnings Call TranscriptFeb 26, 2020€99 (-3.88%)Earnings
- United Therapeutics Corp at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 United Therapeutics Corp Earnings Call TranscriptOct 30, 2019€78 (+0.65%)Earnings
- United Therapeutics Corp at Wedbush PacGrow Healthcare Conference TranscriptAug 13, 2019
- Q2 2019 United Therapeutics Corp Earnings Call TranscriptJul 31, 2019€71.71 (+0.97%)Earnings
- United Therapeutics Corp at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- United Therapeutics Corp at Jefferies Healthcare Conference TranscriptJun 04, 2019
- Q1 2019 United Therapeutics Corp Earnings Call TranscriptMay 01, 2019€90.59Earnings
- United Therapeutics Corp at Oppenheimer Healthcare Conference TranscriptMar 19, 2019
- United Therapeutics Corp at Cowen Health Care Conference TranscriptMar 11, 2019
- Q4 2018 United Therapeutics Corp Earnings Call TranscriptFeb 27, 2019€107.73 (+1.45%)Earnings
United Therapeutics Corp at Cowen Health Care Conference (Virtual) Transcript
Mar 08, 2022 / 04:10PM GMT
Release Date Price:
€155
(-3.73%)
Joseph John;Charles Thome
Cowen and Company, LLC, Research Division - VP of Healthcare
Everyone, good morning, and thank you for joining us on day 2 of Cowen's 42nd Annual Healthcare Conference. I'm Joe Thome, one of the senior biotech analyst here on the team at Cowen. And it is my pleasure to have with me today President and COO, Michael Benkowitz, of United Therapeutics. And I'm going to kick it over to Head of IR, Dewey Steadman, to read some forward-looking statements.
Dewey Steadman
United Therapeutics Corporation - Head of IR
Hi. Good morning. Today's remarks will likely include forward-looking statements. And we encourage you to see our most recent SEC filings, including Form 10-K and Forms 10-Q available on the SEC EDGAR website.
And with that, I'll turn it back over to you, Joe.
Questions & Answers
Joseph John;Charles Thome
Cowen and Company, LLC, Research Division - VP of Healthcare
Thanks, Dewey. Mike, so maybe to just kick things off, obviously,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)